Loading viewer...
investor_presentation
Format: PDF investor_presentation
Intel investor presentation dated July 2020.
EARNINGS Presentation2Disclosures
This presentation contains non -GAAP financial measures. Earnings per share (EPS), gross margin, and operating margin are present ed on a non -
GAAP basis unless otherwise indicated, and this presentation also includes a non -GAAP free cash flow (FCF) measure. The Appendi x provides a
reconciliation of these measures to the most directly comparable GAAP financial measure. The non -GAAP financial measures disclos ed by Intel
should not be considered a substitute for, or superior to, the financial measures prepared in accordance with GAAP. Please r efer to “Explanation
of Non -GAAP Measures” in Intel's quarterly earnings release for a detailed explanation of the adjustments made to the comparable GAAP
measures, the ways management uses the non -GAAP measures, and the reasons why management believes the non -GAAP measures provide
investors with useful supplemental information.
Statements in this presentation that refer to business outlook, future plans, and expectations are forward -looking statements th at involve a
number of risks and uncertainties. Words such as "anticipate," "expect," "intend," "goals," "plans," "believe," "seek," "esti mate," "continue,“
“committed,” “on -track,” ”positioned,” “launching,” "may," "will," “would,” "should," “could,” and variations of such words and similar expressions
are intended to identify such forward -looking statements. Statements that refer to or are based on estimates, forecasts, project ions, uncertain
events or assumptions, including statements relating to total addressable market (TAM) or market opportunity, future products and technology
and the expected availability and benefits of such products and technology, including our 10nm and 7nm process technologies, products, and
product designs, and anticipated trends in our businesses or the markets relevant to them, also identify forward -looking stateme nts. Such
statements are based on management's expectations as of July 23, 2020 and involve many risks and uncertainties that could cau se actual results
to differ materially from those expressed or implied in these forward -looking statements. Important factors that could cause act ual results to
differ materially from the company's expectations, including risks related to the COVID -19 pandemic, are set forth in Intel's ea rnings release dated
July 23, 2020 , which is included as an exhibit to Intel’s Form 8 -K furnished to the SEC on such date. Additional information r egarding these and
other factors that could affect Intel's results is included in Intel's SEC filings, including the company's most recent repor ts on Forms 10 -K and 10 -
Q.Copies of Intel's Form 10 -K, 10 -Q and 8 -K reports may be obtained by visiting our Investor Relations website at www.intc.com or the SEC's
website at www.sec.gov.
All information in this presentation reflects management’s views as of July 23, 2020. Intel does not undertake, and expressl y disclaims any duty,
Preview truncated — download the full document for the complete content.
conference
12 Pages
investor_presentation
26 Pages
Aphios Pharma LLC
investor_presentation
Neometals
investor_presentation
Covestro
Island Pharmaceuticals IPO Roadshow April 2021
investor_presentationinvestor_presentation
30 Pages
Island Pharmaceuticals Limited